ReviewIndian dermatology online journal
Which is the Ideal JAK Inhibitor for Alopecia Areata - Baricitinib, Tofacitinib, Ritlecitinib or Ifidancitinib - Revisiting the Immunomechanisms of the JAK Pathway.
Kabir Sardana et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
21 papers cite it
pooled itcites it